Ultragenyx Stock Filter Stocks by Fundamentals
| RARE Stock | USD 44.28 0.83 1.84% |
Ultragenyx fundamentals help investors to digest information that contributes to Ultragenyx's financial success or failures. It also enables traders to predict the movement of Ultragenyx Stock. The fundamental analysis module provides a way to measure Ultragenyx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ultragenyx stock.
Ultragenyx | Shares Owned by Institutions |
Ultragenyx Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ultragenyx from analyzing Ultragenyx's financial statements. These drivers represent accounts that assess Ultragenyx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ultragenyx's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.4B | 8.4B | 5.7B | 3.2B | 3.5B | 2.4B | |
| Enterprise Value | 2.0B | 7.8B | 5.4B | 3.1B | 3.3B | 2.3B |
Ultragenyx Institutional Holders
Institutional Holdings refers to the ownership stake in Ultragenyx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ultragenyx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ultragenyx's value.| Shares | Rock Springs Capital Management Lp | 2023-12-31 | 1.8 M | Alliancebernstein L.p. | 2023-12-31 | 1.6 M | Marshall Wace Asset Management Ltd | 2023-12-31 | 1.5 M | Baker Bros Advisors Lp | 2023-12-31 | 1.5 M | Geode Capital Management, Llc | 2023-12-31 | 1.3 M | Deutsche Bank Ag | 2023-12-31 | 1.2 M | First Trust Advisors L.p. | 2023-12-31 | 1.2 M | Adage Capital Partners Gp Llc | 2023-12-31 | 1 M | Pictet Asset Manangement Sa | 2023-12-31 | 1 M | Vanguard Group Inc | 2023-12-31 | 8.7 M | Rtw Investments, Llc | 2023-12-31 | 6.9 M |
Ultragenyx Fundamentals
| Return On Equity | -1.93 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (1.40) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 4.07 B | ||||
| Shares Outstanding | 82.34 M | ||||
| Shares Owned By Insiders | 4.10 % | ||||
| Shares Owned By Institutions | 95.90 % | ||||
| Number Of Shares Shorted | 3.92 M | ||||
| Price To Earning | (6.90) X | ||||
| Price To Book | 14.05 X | ||||
| Price To Sales | 8.91 X | ||||
| Revenue | 434.25 M | ||||
| Gross Profit | (370.78 M) | ||||
| EBITDA | (516.85 M) | ||||
| Net Income | (606.64 M) | ||||
| Cash And Equivalents | 542.8 M | ||||
| Cash Per Share | 7.75 X | ||||
| Total Debt | 43.17 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 3.08 X | ||||
| Book Value Per Share | 3.35 X | ||||
| Cash Flow From Operations | (474.81 M) | ||||
| Short Ratio | 5.41 X | ||||
| Earnings Per Share | (8.25) X | ||||
| Price To Earnings To Growth | (0.24) X | ||||
| Target Price | 89.3 | ||||
| Number Of Employees | 1.28 K | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 3.71 B | ||||
| Total Asset | 1.49 B | ||||
| Retained Earnings | (3.39 B) | ||||
| Working Capital | 451.75 M | ||||
| Current Asset | 416.79 M | ||||
| Current Liabilities | 50.43 M | ||||
| Net Asset | 1.49 B |
About Ultragenyx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ultragenyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ultragenyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ultragenyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out Ultragenyx Piotroski F Score and Ultragenyx Altman Z Score analysis. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Ultragenyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.25) | Revenue Per Share 5.905 | Quarterly Revenue Growth 0.233 | Return On Assets (0.23) | Return On Equity (1.93) |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.